• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非转录激活和去泛素化调节 NLRP3 炎症小体的激活。

Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation.

机构信息

Department of Biochemistry and Molecular Biology and the Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

出版信息

J Biol Chem. 2012 Oct 19;287(43):36617-22. doi: 10.1074/jbc.M112.407130. Epub 2012 Sep 4.

DOI:10.1074/jbc.M112.407130
PMID:22948162
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3476327/
Abstract

The NLRP3 inflammasome is a key component of the innate immune response to pathogenic infection and tissue damage. It is also involved in the pathogenesis of a number of human diseases, including gouty arthritis, silicosis, atherosclerosis, and type 2 diabetes. The assembly of the NLRP3 inflammasome requires a priming signal derived from pattern recognition or cytokine receptors, followed by a second signal derived from extracellular ATP, pore-forming toxins, or crystalline materials. How these two signals activate the NLRP3 inflammasome is not yet clear. Here, we show that in mouse macrophages, signaling by the pattern recognition receptor TLR4 through MyD88 can rapidly and non-transcriptionally prime NLRP3 by stimulating its deubiquitination. This process is dependent on mitochondrial reactive oxygen species production and can be inhibited by antioxidants. We further show that signaling by ATP can also induce deubiquitination of NLRP3 by a mechanism that is not sensitive to antioxidants. Pharmacological inhibition of NLRP3 deubiquitination completely blocked NLRP3 activation in both mouse and human cells, indicating that deubiquitination of NLRP3 is required for its activation. Our findings suggest that NLRP3 is activated by a two-step deubiquitination mechanism initiated by Toll-like receptor signaling and mitochondrial reactive oxygen species and further potentiated by ATP, which could explain how NLRP3 is activated by diverse danger signals.

摘要

NLRP3 炎性小体是先天免疫反应对病原感染和组织损伤的关键组成部分。它也参与了多种人类疾病的发病机制,包括痛风性关节炎、矽肺、动脉粥样硬化和 2 型糖尿病。NLRP3 炎性小体的组装需要源自模式识别或细胞因子受体的初始信号,然后是源自细胞外 ATP、孔形成毒素或结晶物质的第二信号。这两个信号如何激活 NLRP3 炎性小体尚不清楚。在这里,我们表明在小鼠巨噬细胞中,通过 MyD88 的模式识别受体 TLR4 的信号可以通过刺激其去泛素化来快速且非转录地启动 NLRP3。这个过程依赖于线粒体活性氧的产生,并且可以被抗氧化剂抑制。我们进一步表明,ATP 的信号也可以通过一种对抗氧化剂不敏感的机制诱导 NLRP3 的去泛素化。NLRP3 去泛素化的药理学抑制完全阻断了小鼠和人细胞中 NLRP3 的激活,表明 NLRP3 的去泛素化是其激活所必需的。我们的发现表明,NLRP3 通过由 Toll 样受体信号和线粒体活性氧启动的两步去泛素化机制激活,并且进一步被 ATP 增强,这可以解释 NLRP3 如何被多种危险信号激活。

相似文献

1
Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation.非转录激活和去泛素化调节 NLRP3 炎症小体的激活。
J Biol Chem. 2012 Oct 19;287(43):36617-22. doi: 10.1074/jbc.M112.407130. Epub 2012 Sep 4.
2
Molecular hydrogen inhibits lipopolysaccharide-triggered NLRP3 inflammasome activation in macrophages by targeting the mitochondrial reactive oxygen species.分子氢通过靶向线粒体活性氧抑制巨噬细胞中脂多糖触发的NLRP3炎性小体激活。
Biochim Biophys Acta. 2016 Jan;1863(1):50-5. doi: 10.1016/j.bbamcr.2015.10.012. Epub 2015 Oct 18.
3
Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis.在饮食性脂肪性肝炎中,骨髓来源和非骨髓来源的细胞均以MyD88依赖的方式促进AIM2和NLRP3炎性小体的激活。
Liver Int. 2014 Oct;34(9):1402-13. doi: 10.1111/liv.12537. Epub 2014 Apr 17.
4
Mechanisms that lead to the regulation of NLRP3 inflammasome expression and activation in human dental pulp fibroblasts.导致人牙髓成纤维细胞中NLRP3炎性小体表达和激活调控的机制。
Mol Immunol. 2015 Aug;66(2):253-62. doi: 10.1016/j.molimm.2015.03.009. Epub 2015 Apr 2.
5
Mesenchymal stem/stromal cells inhibit the NLRP3 inflammasome by decreasing mitochondrial reactive oxygen species.间充质干细胞/基质细胞通过减少线粒体活性氧来抑制 NLRP3 炎性体。
Stem Cells. 2014 Jun;32(6):1553-63. doi: 10.1002/stem.1608.
6
Chemotherapeutic Agent Paclitaxel Mediates Priming of NLRP3 Inflammasome Activation.化疗药物紫杉醇介导 NLRP3 炎性小体的激活预刺激。
Front Immunol. 2019 May 16;10:1108. doi: 10.3389/fimmu.2019.01108. eCollection 2019.
7
Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm.巨噬细胞中线粒体氧化应激引起的炎性小体激活会导致血管紧张素II诱导的主动脉瘤的发展。
Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):127-36. doi: 10.1161/ATVBAHA.114.303763. Epub 2014 Nov 6.
8
Tripartite-motif protein 30 negatively regulates NLRP3 inflammasome activation by modulating reactive oxygen species production.三结构域蛋白 30 通过调节活性氧产生负调控 NLRP3 炎性小体激活。
J Immunol. 2010 Dec 15;185(12):7699-705. doi: 10.4049/jimmunol.1001099. Epub 2010 Nov 3.
9
Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.血清淀粉样蛋白 A 通过 P2X7 受体和一种组织蛋白酶 B 敏感途径激活 NLRP3 炎性体。
J Immunol. 2011 Jun 1;186(11):6119-28. doi: 10.4049/jimmunol.1002843. Epub 2011 Apr 20.
10
Rotenone-induced Impairment of Mitochondrial Electron Transport Chain Confers a Selective Priming Signal for NLRP3 Inflammasome Activation.鱼藤酮诱导的线粒体电子传递链损伤为NLRP3炎性小体激活赋予了选择性启动信号。
J Biol Chem. 2015 Nov 6;290(45):27425-27437. doi: 10.1074/jbc.M115.667063. Epub 2015 Sep 28.

引用本文的文献

1
Type A cholesterol-dependent cytolysins translocate to the trans-Golgi network for NLRP3 inflammasome activation.A型胆固醇依赖性细胞溶素转位至反式高尔基体网络以激活NLRP3炎性小体。
Nat Immunol. 2025 Sep 5. doi: 10.1038/s41590-025-02277-6.
2
Innate immune mechanisms of infection: what we know and potential conserved mechanisms affecting sleep during infection.感染的固有免疫机制:我们所了解的以及感染期间影响睡眠的潜在保守机制。
Neurobiol Sleep Circadian Rhythms. 2025 Apr 21;18(Suppl):100121. doi: 10.1016/j.nbscr.2025.100121. eCollection 2025 May.
3
Molecular Mechanism of NLRP3 Inflammasome in Inflammatory Diseases and Tumors.NLRP3炎性小体在炎症性疾病和肿瘤中的分子机制
Immun Inflamm Dis. 2025 Jul;13(7):e70213. doi: 10.1002/iid3.70213.
4
NLRP3 Inflammasome and Inflammatory Response in Aging Disorders: The Entanglement of Redox Modulation in Different Outcomes.NLRP3炎性小体与衰老相关疾病中的炎症反应:氧化还原调节在不同结果中的纠结
Cells. 2025 Jun 29;14(13):994. doi: 10.3390/cells14130994.
5
Pattern recognition receptors: function, regulation and therapeutic potential.模式识别受体:功能、调控及治疗潜力
Signal Transduct Target Ther. 2025 Jul 11;10(1):216. doi: 10.1038/s41392-025-02264-1.
6
Mechanisms of SIRT1/SIRT3-mediated reduction of mitochondrial regeneration and inflammatory response in diabetic cerebral ischemia-reperfusion injury.SIRT1/SIRT3介导糖尿病性脑缺血再灌注损伤中线粒体再生减少及炎症反应的机制
Metab Brain Dis. 2025 Jun 28;40(6):236. doi: 10.1007/s11011-025-01662-2.
7
Clustering of NLRP3 induced by membrane or protein scaffolds promotes inflammasome assembly.由膜或蛋白质支架诱导的NLRP3聚集促进炎性小体组装。
Nat Commun. 2025 May 27;16(1):4887. doi: 10.1038/s41467-025-60277-4.
8
The immune system in cardiovascular diseases: from basic mechanisms to therapeutic implications.心血管疾病中的免疫系统:从基本机制到治疗意义
Signal Transduct Target Ther. 2025 May 23;10(1):166. doi: 10.1038/s41392-025-02220-z.
9
Role of macrophage ATP metabolism disorder in SiO‑induced pulmonary fibrosis: a review.巨噬细胞ATP代谢紊乱在二氧化硅诱导的肺纤维化中的作用:综述
Purinergic Signal. 2025 May 13. doi: 10.1007/s11302-025-10093-8.
10
SARS-CoV-2 ORF3a drives dynamic dense body formation for optimal viral infectivity.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的开放阅读框3a(ORF3a)驱动动态致密小体形成以实现最佳病毒感染性。
Nat Commun. 2025 May 12;16(1):4393. doi: 10.1038/s41467-025-59475-x.

本文引用的文献

1
A role for the NLRP3 inflammasome in metabolic diseases--did Warburg miss inflammation?NLRP3 炎性体在代谢性疾病中的作用——难道沃伯格错过了炎症?
Nat Immunol. 2012 Mar 19;13(4):352-7. doi: 10.1038/ni.2228.
2
Sensing and reacting to microbes through the inflammasomes.通过炎症小体感知和应对微生物。
Nat Immunol. 2012 Mar 19;13(4):325-32. doi: 10.1038/ni.2231.
3
Inflammasomes in health and disease.炎症小体在健康与疾病中的作用。
Nature. 2012 Jan 18;481(7381):278-86. doi: 10.1038/nature10759.
4
Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome.前沿:活性氧簇抑制剂可阻断 NLRP3 炎性小体的初始激活,但不阻断其活化。
J Immunol. 2011 Jul 15;187(2):613-7. doi: 10.4049/jimmunol.1100613. Epub 2011 Jun 15.
5
Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome.自噬蛋白通过抑制 NALP3 炎性小体介导的线粒体 DNA 的释放来调节先天免疫反应。
Nat Immunol. 2011 Mar;12(3):222-30. doi: 10.1038/ni.1980. Epub 2010 Dec 12.
6
A role for mitochondria in NLRP3 inflammasome activation.线粒体在 NLRP3 炎性小体激活中的作用。
Nature. 2011 Jan 13;469(7329):221-5. doi: 10.1038/nature09663. Epub 2010 Dec 1.
7
Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella.NLRP3 和 NLRC4 炎症小体受体在宿主防御沙门氏菌中的冗余作用。
J Exp Med. 2010 Aug 2;207(8):1745-55. doi: 10.1084/jem.20100257. Epub 2010 Jul 5.
8
NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?NLRP3 炎性小体激活:ROS 产生的多种信号通路汇聚?
Nat Rev Immunol. 2010 Mar;10(3):210-5. doi: 10.1038/nri2725. Epub 2010 Feb 19.
9
Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome.抗炎化合物小白菊内酯和 Bay 11-7082 是炎症小体的直接抑制剂。
J Biol Chem. 2010 Mar 26;285(13):9792-9802. doi: 10.1074/jbc.M109.082305. Epub 2010 Jan 21.
10
Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression.前沿:NF-κB激活模式识别和细胞因子受体通过调节NLRP3表达许可NLRP3炎性小体激活。
J Immunol. 2009 Jul 15;183(2):787-91. doi: 10.4049/jimmunol.0901363. Epub 2009 Jul 1.